secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2023-08-16T23:59:59+00:00
Accession:  0001104659-23-092205
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TELA Bio launches OviTex PRS Long-Term Resorbable for plastic and reconstructive surgery
--------------------------------------------------------------------------------

- OviTex PRS Long-Term Resorbable is intended for soft tissue repair or reinforcement in plastic and reconstructive surgery.
- Product supplements existing OviTex PRS portfolio which includes Permanent and Short-Term Resorbable configurations.
- Features include bi-directional stretch and a fully resorbable, long-term polymer for reinforcement.
- OviTex PRS has over 6,800 implantations at more than 400 healthcare facilities.
- CEO Antony Koblish says addition allows surgeons to address indications requiring longer term reinforcement without permanent materials.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465923092205/0001104659-23-092205-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465923092205/tm2323862d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-092205

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer